Breast Cancer, Glioma
Conditions
Brief summary
This study evaluates the frequency of the spontaneous T cells specific CD4 answers of tumoral antigens breast cancer and glioma.
Interventions
Sponsors
Centre Hospitalier Universitaire de Besancon
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Performance status 0,1 or 2 * breast cancer or glioma * Arm glioma: patients without anti-tumoral treatment * Arm breast cancer: inclusion before treatment * Arm breast cancer HER2: patients with current therapy
Exclusion criteria
* Psychiatric disease compromising the understanding of the information or the realization of the study * vulnerable People according to the law (minors, adults under protection, private persons of freedom ...) * Unaffiliated People to the Social Security * People being for the period of exclusion from another study * Life expectancy estimated unless 3 months. * For patients in Arm glioma: patients having already begun a systematic treatment. * For patients with a breast cancer: patient already under current therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Spontaneous immune responses of T cells CD4 specific tumor antigens | 15 months |
Secondary
| Measure | Time frame |
|---|---|
| T cells level | 15 months |
Countries
France
Outcome results
None listed